Development and Validation of a Combined Ferroptosis and Immune Prognostic Classifier for Hepatocellular Carcinoma
Background Immunotherapy and sorafenib exert anti-tumor effects via ferroptosis, but reliable biomarkers for the individual treatment and prognosis prediction of hepatocellular carcinoma (HCC) based on the ferroptosis and immune status remain lacking. Methods Ferroptosis-related genes (FRGs) were id...
Saved in:
Main Authors: | Yang Liu, Xi Zhang, Junjun Zhang, Juan Tan, Jie Li, Zewen Song |
---|---|
格式: | Artigo |
語言: | 英语 |
出版: |
2020
|
在線閱讀: | https://doi.org/10.3389/fcell.2020.596679 https://www.frontiersin.org/articles/10.3389/fcell.2020.596679/pdf |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|
相似書籍
-
Development and Validation of a Combined Ferroptosis and Immune Prognostic Classifier for Hepatocellular Carcinoma
由: Liu, Yang, et al.
出版: (2020) -
Combination of ferroptosis and pyroptosis to construct a prognostic classifier and predict immune landscape, chemotherapeutic efficacy and immunosuppressive molecules in hepatocellular carcinoma
由: Xu, Lijun, et al.
出版: (2022) -
Bcl-2 Associated Athanogene 2 (BAG2) is Associated With Progression and Prognosis of Hepatocellular Carcinoma: A Bioinformatics-Based Analysis
由: Zhang, Xi, et al.
出版: (2021) -
Construction and Validation of a Combined Ferroptosis and Hypoxia Prognostic Signature for Hepatocellular Carcinoma
由: Wen, Kai, et al.
出版: (2021) -
Development and Validation of a Combined Hypoxia and Immune Prognostic Classifier for Lung Adenocarcinoma
由: Huang, Hua, et al.
出版: (2022)